Literature DB >> 11848495

Heparanase gene expression and metastatic potential in human gastric cancer.

K Endo1, U Maejara, H Baba, E Tokunaga, T Koga, Y Ikeda, Y Toh, S Kohnoe, T Okamura, M Nakajima, K Sugimachi.   

Abstract

BACKGROUND: Heparanase has been reported to play an important role in tumor progression and metastasis. We examined the relationship between heparanase mRNA expression and biological factors regarding invasion and metastasis of human gastric cancer.
MATERIALS AND METHODS: In 63 human gastric carcinomas, 42 adjacent normal gastric tissues and four gastric cancer cell lines, heparanase mRNA expression was evaluated using reverse transcription PCR (RT-PCR). Total RNA obtained from human peripheral blood (PB) leucocyte and placenta were used as positive controls. The relationship between heparanase mRNA expression and various clinicopathological factors were analyzed.
RESULTS: The heparanase mRNA expression evaluated with RT-PCR revealed that 31 out of 63 gastric cancer tissues (49%), 11 out of 42 normal gastric tissues (26%) and 4 gastric cancer cell lines were positive. The positive rate in cancer tissues was significantly higher than that in normal tissues (p<0.05). In the heparanase mRNA-positive cancer tissues, venous invasion was frequent (p<0.05) and the histological differential grade was significantly poorer than in negative cases (p<0.01).
CONCLUSION: We propose that heparanase mRNA expression is involved in invasion and development of human gastric cancer and detection of this expression may be a factor related to metastasis and prognosis of such patients.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11848495

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  8 in total

1.  Significance of heparanase in cancer and inflammation.

Authors:  Israel Vlodavsky; Phillip Beckhove; Immanuel Lerner; Claudio Pisano; Amichai Meirovitz; Neta Ilan; Michael Elkin
Journal:  Cancer Microenviron       Date:  2011-08-03

2.  Increased levels of β-catenin, LEF-1, and HPA-1 correlate with poor prognosis for acral melanoma with negative BRAF and NRAS mutation in BRAF exons 11 and 15 and NRAS exons 1 and 2.

Authors:  Sanxiong Xu; Zuozhang Yang; Jinyu Zhang; Yongxin Jiang; Yongbin Chen; Hongjun Li; Xuefeng Liu; Da Xu; Yanjin Chen; Yihao Yang; Ya Zhang; Dongxu Li; Junfeng Xia
Journal:  DNA Cell Biol       Date:  2015-01       Impact factor: 3.311

3.  Heparanase mRNA expression and point mutation in hepatocellular carcinoma.

Authors:  Xiao-Peng Chen; Yin-Bib Liu; Jing Rui; Shu-You Peng; Cheng-Hong Peng; Zi-Yan Zhou; Liang-Hui Shi; Hong-Wei Shen; Bin Xu
Journal:  World J Gastroenterol       Date:  2004-10-01       Impact factor: 5.742

4.  cDNA suppression subtraction library for screening down-regulated genes in gastric carcinoma.

Authors:  Jian-Jun Du; Ke-Feng Dou; Shu-You Peng; Hua-Sheng Xiao; Wei-Zhong Wang; Wen-Xian Guan; Zhong-Hua Wang; Zhi-Qing Gao; Ying-Bin Liu
Journal:  World J Gastroenterol       Date:  2003-07       Impact factor: 5.742

5.  Expression of heparanase gene, CD44v6, MMP-7 and nm23 protein and their relationship with the invasion and metastasis of gastric carcinomas.

Authors:  Jun-Qiang Chen; Wen-Hua Zhan; Yu-Long He; Jun-Sheng Peng; Jian-Ping Wang; Shi-Rong Cai; Jin-Ping Ma
Journal:  World J Gastroenterol       Date:  2004-03-15       Impact factor: 5.742

6.  A novel gene, GCRG224, is differentially expressed in human gastric mucosa.

Authors:  Gang-Shi Wang; Meng-Wei Wang; Ben-Yan Wu; Wei-Di You; Xin-Yan Yang
Journal:  World J Gastroenterol       Date:  2003-01       Impact factor: 5.742

7.  Polymorphisms and a haplotype in heparanase gene associations with the progression and prognosis of gastric cancer in a northern Chinese population.

Authors:  Ai-Lin Li; Yong-Xi Song; Zhen-Ning Wang; Peng Gao; Yuan Miao; Jin-Liang Zhu; Zhen-Yu Yue; Hui-Mian Xu
Journal:  PLoS One       Date:  2012-01-20       Impact factor: 3.240

Review 8.  The Role of Heparanase and Sulfatases in the Modification of Heparan Sulfate Proteoglycans within the Tumor Microenvironment and Opportunities for Novel Cancer Therapeutics.

Authors:  Edward Hammond; Ashwani Khurana; Viji Shridhar; Keith Dredge
Journal:  Front Oncol       Date:  2014-07-24       Impact factor: 6.244

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.